tiprankstipranks
Trending News
More News >
Dlaboratory Sweden AB (SE:DLAB)
:DLAB

Dlaboratory Sweden AB (DLAB) AI Stock Analysis

Compare
0 Followers

Top Page

SE:DLAB

Dlaboratory Sweden AB

(DLAB)

Select Model
Select Model
Select Model
Neutral 44 (OpenAI - 5.2)
Rating:44Neutral
Price Target:
kr2.50
▲(8.70% Upside)
Action:ReiteratedDate:12/30/25
The score is mainly held back by weak financial performance—ongoing losses, declining revenue, and negative/free cash flow with worsening FCF—despite the benefit of zero debt. Technical indicators are broadly neutral and do not provide a strong momentum tailwind, while valuation is constrained by loss-making results (negative P/E) and no dividend yield support.
Positive Factors
Low leverage / zero debt
Zero debt meaningfully reduces fixed financial obligations and bankruptcy risk, giving management flexibility to prioritize operational fixes or selective investments. For a cash-burning renewable utility, low leverage materially extends runway and preserves optionality while execution on profitability proceeds.
Improving gross margins
A sharp improvement in gross margin indicates better unit economics or favorable mix, which strengthens the path to operating profitability. If sustained, higher gross margins can offset revenue softness and reduce the scale of required cost cuts or external funding to reach break-even.
Free cash flow trending less negative
Free cash flow being less negative than prior years signals early progress in cutting cash burn or improving working capital. Continued improvement in FCF would enhance self-funding potential, reduce dependency on external capital, and improve financial resilience over the next several months.
Negative Factors
Persistent operating losses
Consistent negative EBIT and net margins (~-17%) show the core operations are loss-making, eroding retained earnings and limiting reinvestment capacity. Without durable margin recovery or revenue growth, losses will continue to pressure liquidity and force financing or restructuring choices.
Declining top-line
A falling revenue trend (~-6.8% TTM) signals weakening demand or execution problems, undermining scalability and the ability to leverage improved gross margins. Persistent revenue decline makes it harder to achieve sustainable profitability and exacerbates cash burn risks absent new growth drivers.
Eroding equity and very negative ROE
A materially reduced equity base and deeply negative ROE (~-122%) reflect capital erosion from ongoing losses, shrinking the solvency buffer. This increases the likelihood of dilutive capital raises, weakens investor confidence, and signals poor capital efficiency that hampers long-term value creation.

Dlaboratory Sweden AB (DLAB) vs. iShares MSCI Sweden ETF (EWD)

Dlaboratory Sweden AB Business Overview & Revenue Model

Company DescriptionDlaboratory Sweden AB (publ) operates as a cleantech company in Sweden. It provides dInsight Analytics platform that connects and collects grid data; analyses to unlock critical information; categorizes and visualizes; and transform the information in meaningful context and actionable knowledge. The company was incorporated in 2010 and is based in Lund, Sweden.
How the Company Makes MoneyDlaboratory Sweden AB (DLAB) generates revenue primarily through the sale of its software solutions and services to utility companies and other stakeholders in the energy sector. The company's key revenue streams include subscription fees for access to its analytics platform, licensing of its technology, and consulting services related to grid optimization and management. Additionally, DLAB may engage in strategic partnerships with energy providers and technology firms to expand its reach and enhance its offerings, which can contribute to its earnings.

Dlaboratory Sweden AB Financial Statement Overview

Summary
Financials are weak overall: TTM revenue declined (~-6.8%), profitability is negative (EBIT and net margins about -17%), and cash flow is still negative (TTM OCF -1.96M; FCF -3.61M with ~-54% deterioration). The key offset is very low leverage (zero debt) and improved gross margin (~47% TTM vs ~21% in FY2024), but shrinking equity and deeply negative ROE (~-122%) keep the risk elevated.
Income Statement
28
Negative
TTM (Trailing-Twelve-Months) revenue is 44.16M, down ~6.8% versus the prior period, pointing to weakening top-line momentum. Profitability remains the central issue: the company is still loss-making at the operating level (EBIT margin about -17%) and at the bottom line (net margin about -17%). A positive is the sharp improvement in gross margin versus FY2024 (TTM ~47% vs ~21%), but overall earnings are still negative and margins have not stabilized into consistent profitability.
Balance Sheet
52
Neutral
Leverage is very low, with zero debt in TTM and FY2024, which reduces financial risk. However, the equity base has contracted meaningfully (equity down from 11.17M in FY2024 to 3.24M in TTM), and returns remain deeply negative (TTM return on equity about -122%), reflecting ongoing losses and pressure on capital. Overall, the balance sheet is not burdened by debt, but shrinking equity and negative returns are notable concerns.
Cash Flow
24
Negative
Cash generation remains weak: TTM operating cash flow is -1.96M and free cash flow is -3.61M, meaning the business is still consuming cash. Free cash flow deterioration is significant (TTM free cash flow growth about -54%), indicating worsening cash burn versus the prior period. A modest positive is that TTM free cash flow is less negative than in several earlier years, but the company has not yet demonstrated sustained positive operating cash flow to self-fund operations.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue44.16M46.78M44.87M45.76M18.05M4.75M
Gross Profit20.96M9.96M36.40M40.20M17.83M2.63M
EBITDA-5.21M-3.55M-8.38M-6.44M-14.23M-12.74M
Net Income-7.63M-6.19M-11.05M-8.99M-16.13M-13.77M
Balance Sheet
Total Assets16.65M24.65M30.62M37.97M48.20M10.74M
Cash, Cash Equivalents and Short-Term Investments993.00K5.74M10.53M14.71M28.16M7.19M
Total Debt0.000.00440.00K920.00K1.57M2.55M
Total Liabilities13.41M13.48M13.25M9.74M11.32M4.48M
Stockholders Equity3.24M11.17M17.37M28.23M36.87M6.26M
Cash Flow
Free Cash Flow-3.61M-3.08M-3.93M-13.15M-12.99M-9.45M
Operating Cash Flow-1.96M-3.08M-3.93M-13.15M-12.80M-9.45M
Investing Cash Flow-1.97M-1.27M0.000.00-11.96M0.00
Financing Cash Flow-92.00K-440.00K-248.00K-303.00K45.73M13.38M

Dlaboratory Sweden AB Technical Analysis

Technical Analysis Sentiment
Positive
Last Price2.30
Price Trends
50DMA
2.48
Positive
100DMA
2.34
Positive
200DMA
2.38
Positive
Market Momentum
MACD
<0.01
Positive
RSI
49.24
Neutral
STOCH
36.84
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:DLAB, the sentiment is Positive. The current price of 2.3 is below the 20-day moving average (MA) of 2.53, below the 50-day MA of 2.48, and below the 200-day MA of 2.38, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 49.24 is Neutral, neither overbought nor oversold. The STOCH value of 36.84 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:DLAB.

Dlaboratory Sweden AB Peers Comparison

Overall Rating
UnderperformOutperform
Sector (66)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
66
Neutral
$17.65B18.105.60%3.62%6.62%11.55%
44
Neutral
kr40.33M-5.28-109.03%-4.02%6.77%
44
Neutral
kr140.72M-3.35-5.97%-100.00%31.68%
43
Neutral
kr109.04M-0.63-47.34%-36.89%33.50%
* Utilities Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SE:DLAB
Dlaboratory Sweden AB
2.50
0.38
17.92%
SE:CLIME.B
Climeon AB
2.18
-1.15
-34.56%
SE:MINEST
Minesto AB
0.58
-1.75
-74.99%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 30, 2025